Systemic Reactions to Dust Mite Subcutaneous Immunotherapy: A 3-Year Follow-up Study
Main Authors: | Dong, Xiang, Huang, Nan, Li, Wenjing, Hu, Lintao, Wang, Xiaolong, Wang, Yin, Xiang, Ning, Liu, Guanghui, Zhu, Rongfei |
---|---|
Format: | Online |
Language: | English |
Published: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921696/ |
Similar Items
-
Immunotherapy – 2077. Allergen specific immunotherapy in allergic conjuntivitis due to dust mite
by: Pawar, Sanjay
Published: (2013) -
Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis
by: Kim, Myoung-Eun, et al.
Published: (2011) -
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
by: Rieker-Schwienbacher, Juliane, et al.
Published: (2013) -
Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma
by: HUI, YU, et al.
Published: (2014) -
Three-Year Follow-up Results of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitized to House Dust Mites
by: Kim, Shin Hye, et al.
Published: (2015)